Biotech penny stocks have proven to be one of the most exciting equity classes in history. Fast-growing sectors like biotechnology have experts believing that it is going to grow in the years to come. When a sector grows rapidly, then there is a definite chance of even the smaller companies recording decent growth. Even companies which have had setbacks can make a comeback.
When you talk about biotech stocks, there are likely periods of success and failure especially considering phase trials and the like. But there is a case to be made about biotech penny stocks. On that note, here is a look at 3 biotech penny stocks that should be on the watch lists of most investors.
One of the first biotech penny stocks to watch due to recent performance is Geron Corporation (GERN Stock Report). Since early August, GERN stock has climbed considerably due to the highly impressive progress of its product imetelstat. Since then the stock has performed well and gained as much as 30%. It has been one of the best performing penny stocks in the biotech space during the last 2 weeks.
However, it is not only the progress of imetelstat that is catching attention. Geron has also revealed that it has a ready pipeline of medicines that could show promise for the company as well. Due to this progress, Geron has also attracted attention from analysts. Most recently, H.C. Wainwright initiated coverage on the company with a “BUY” rating and a $4 price target.
Nabriva Therapeutics (NBRV Stock Report) made a major announcement this Monday that saw its stock climb as much as 32% this week so far. The company is primarily engaged in the production of anti-infective medicines. One of the most well-known products it has produced is Xenleta.
Earlier this week, Nabriva announced that the medicine has now been approved for distribution in the United States by the FDA. It goes without saying that it is a major development for a company within the biotech industry. one that could propel the company’s revenues to new heights in the coming quarters.
Intec Pharma (NTEC Stock Report) is the last company on this list of penny stocks. The company has seen interest building most of the week. Friday, this came to a head as NTEC stock saw its largest move and highest volume day since August 28. Though there hasn’t been any formal penny stock news, the company is likely coming off of a series of conferences.
Earlier this month, Intec revealed that it would be participating in investor conferences throughout the month of September. The most recent conference was the HC Wainwright Global Investment Conference held between September 8-10. Its next appearance will be at Ladenburg Thalmann’s Healthcare conference on the 24th.
Click To View NTEC Form 4 Filings
What may have also helped sentiment is the fact that the company’s insiders are buying stock. On August 28, it was shown that Intec Chairman, John Kozarish purchased 100,000 shares of the company at an average price of $0.459.
The Transparent Traders Blackbox 💸 Amazingly simple!
What’s in the box?
Our Blackbox is the first-ever to be created that specifically alerts for swing trades. It will also alert for bullish & bearish day trades.
The Blackbox runs off of multiple algorithms and uses predictive A.I. to locate the most accurate day or swing trades that it calculates to give the best chance for success.
Transparent Traders
Private group · 6,900 members
Join Group
Transparent Traders exists to solve the critical issues facing our traders, both large and small. Our unique approach is not only what differentiates ...
Contact Us: We Can Help the Trading Community Learn About Your Company or Product.
Post a Comment